The Global Osseointegration Implants Market, by Product Type (Dental Implants, Knee Implants, Hip Implants, Spinal Implants and Others), By Material Type (Titanium Implants, Zirconia Implants, Stainless Steel Implants, Ceramic Implants, and Others), By End User (Hospitals, Ambulatory Centers, Dental and Orthopedic Clinics, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) was valued at US$ 5,672.3 million in 2017, and is projected to exhibit a CAGR of 6.72% over the forecast period (2018 - 2026).

Osseointegration implant is an endosteal implant that contain pores into which osteoblasts and supporting connective tissue can migrate. This implant is placed between living bone and surface of a load-bearing artificial implant. It is a fixation of alloplastic materials with a living part of patient for treatment purpose. Osseointegration implants has become a vital part of cosmetic dentistry industry due to the increasing the disposable income and increasing consciousness about the advanced technology among the patients and healthcare providers. Key players in osseointegration implants market are launching innovative products to generate a reasonable amount of share in the market. For instance, in June 2017, DePuy Synthes Companies launched Fenestrated Screw Systems- VIPER and EXPEDIUM in the U.S. market. These products would re-establish the correct posture of the spinal column in patients with advanced stage spinal tumors. Gradually increasing number of people suffering from edentulous is propelling demand for osseointegration implants. According to Indonesian Family Life Survey (IFLS), overall prevalence of edentulous was 7.2-29.8% in the age group >80 years and older in Indonesia in 2015. Furthermore, according to the report published by Public Health England, 2016, the highest prevalence of edentulous in England was around 17.8% in the age group of 65 to 74-years. Moreover, development of advanced technologies for dental implants and increasing number of dental practitioners are supporting growth of the osseointegration implants market.   Increasing incidence of degenerative spinal conditions is another factor driving growth of the global osseointegration implants market. For instance, according to the National Spinal Cord Injury Statistical Center (NSCISC), 2017, around 17,500 new Spinal Cord Injury (SCI) cases are performed annually in the U.S. Moreover, an estimated amount of about 285,000 persons in the U.S. are living with SCI in 2017.

Browse 27 Market Data Tables and 24 Figures spread through 153 Pages and in-depth TOC on "Osseointegration Implants Market, by Product Type (Dental Implants, Knee Implants, Hip Implants, Spinal Implants and Others), By Material Type (Titanium Implants, Zirconia Implants, Stainless Steel Implants, Ceramic Implants and Others), By End User (Hospitals, Ambulatory Centers, Dental and Orthopedic Clinics and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Global Forecast to 2026"

To know the latest trends and insights related to Osseointegration Implants market, click the link below:

https://www.coherentmarketinsights.com/market-insight/osseointegration-implants-market-2384

Key players in osseointegration implants market are adopting various strategies such as mergers, acquisitions, collaborations, and new product launch to maintain their position in the market and to gain a stronger foothold in the market. Moreover, a large number of companies investing in developing markets and distribution strategies has contributed to the transformation of medical sector in emerging economies. For instance, in January 2017, Integrum SE introduced the new OPRA Implant System Platform G which is used for transfemoral patients. This new system is CE labeled and approved by the FDA which has improved the mechanical performance of the system by simplifying the surgical procedure and enhancing osseointegration. The market in emerging economies is propelled by supportive government initiatives and growing awareness among the consumer as well as the healthcare providers for the use of osseointegration implants, and growing medical tourism in these regions. Furthermore, increasing consumption of unhealthy food and sedentary lifestyle has contributed to an increase disease prevalence, which have a positive impact on the growth of the osseointegration implants market. According to the World Health Organization (WHO), more than 1.9 billion adults were overweight and around 650 million people were obese worldwide in 2016.

Key Takeaways of the Osseointegration Implants Market:

  • The global osseointegration implants market is expected to expand at a CAGR of 6.72% during the forecast period (2018–2026), owing to rising number of joint replacement surgeries. According to American Joint Replacement Registry (AJRR), in 2015, over 97, 673 primary hip replacement procedures and 87,593 primary knee replacement procedures were performed in the U.S.
  • Among product type, knee implants segment is expected to hold the major revenue share in 2018, owing to increasing incidence of osteoarthritis and rheumatoid arthritis among geriatric population
  • Among material type, ceramic implants segment is projected to have the highest CAGR during the forecast period, owing to its biocompatibility and aesthetic appearance.
  • Among end user, the hospital segment is expected to hold the major revenue share in 2018, owing to high rate of hospitalization due to rising number of joint replacement procedures
  • Major players operating in the global osseointegration implants market include Medtronic plc, Stryker Corporation, Zimmer Biomet Holdings, Smith and Nephew Plc., Straumann AG Group, Integrum SE, Southern Implants and ConMed Corporation.
Existing Clientele

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients

Our Trusted Patner